Infezioni urinarie basse e cistite interstiziale: disfunzione epiteliale e ruolo del tratto urinario inferiore
on August 08, 2026

Lower urinary tract infections and interstitial cystitis: epithelial dysfunction and the role of the lower urinary tract

From the GAG barrier theory to an integrated nutraceutical strategy

The pathophysiology of lower urinary tract infections (UTIs) and interstitial cystitis (IC) is based on a key element: the integrity of the lower urinary tract epithelium. As early as 1996, Lowell Parsons hypothesized that epithelial dysfunction represents the initiating event of the pathology, paving the way for a view that is now widely shared.

The urothelial barrier: an active defense system

Under physiological conditions, the urothelium is not a simple passive barrier, but a highly specialized dynamic system. Its most important element is the glycosaminoglycan (GAG) layer, composed of:

  • hyaluronic acid
  • chondroitin sulfate
  • heparan sulfate
  • keratan sulfate

This coating prevents direct contact between urine and the underlying tissues, protecting the bladder from:

  • irritating substances
  • pathogens
  • variations in pH and osmolarity

When the barrier breaks down

Compromise of the GAG layer leads to:

  • increased bladder permeability
  • entry of solutes (particularly potassium)
  • activation of an inflammatory cascade

The mechanisms involved include:

  • release of pro-inflammatory cytokines
  • mast cell degranulation
  • activation of nerve endings

This process leads to chronic inflammation, pain, and bladder hypersensitivity.

Bacterial adhesion: the key to UTIs

In the case of UTIs, the main culprit is Escherichia coli (UPEC), responsible for 80–90% of infections.

The critical step is adhesion to the urothelium via:

  • type 1 fimbriae (FimH lectin)
  • P-fimbriae

This adhesion enables:

  • colonization
  • biofilm formation
  • resistance to urinary clearance

Nutraceutical rationale: targeting multiple pathways

A modern approach does not limit itself to “killing the bacterium,” but aims to interrupt pathogenic mechanisms.

1. D-mannose: competitive inhibition of adhesion

D-mannose acts as a “decoy receptor”:

  • it binds to the FimH lectin
  • prevents bacterial adhesion
  • promotes elimination with urination

Clinical evidence:

Randomized studies show a reduction in recurrences comparable to antibiotic prophylaxis

  • a better safety profile (Kranjčec et al., 2014)

    • 2. Cranberry: complementary anti-adhesive action

    Vaccinium macrocarpon

    Proanthocyanidins (PAC-A):

    • inhibit P-fimbriae
    • reduce biofilm formation
    • modulate inflammation

    Evidence:

    • Cochrane meta-analysis: significant reduction in recurrent UTIs
    • Greater efficacy with standardized extracts in PAC-A

    3. Birch: urinary “flushing” effect

    Betula pubescens

    Flavonoids:

    • increase diuresis
    • promote the elimination of bacteria
    • reduce urinary stasis

    Additional effects:

    • mild anti-inflammatory activity
    • support of renal function

    4. Hibiscus: modulation of the urinary environment

    Hibiscus sabdariffa

    Main mechanisms:

    • urinary acidification
    • antimicrobial and anti-biofilm activity
    • antioxidant action

    Evidence:

    • In vitro studies demonstrate inhibition of bacterial growth
    • Reduction of microbial virulence

    Synergy of action: the real strength

    The combination of the four active ingredients allows action on multiple levels:

    • anti-adhesion → D-mannose + cranberry
    • mechanical elimination → birch + hibiscus
    • modulation of the urinary environment → hibiscus
    • inflammatory control → cranberry + birch

    This strategy:

    • reduces the bacterial load
    • limits colonization
    • prevents recurrence
    • does not induce antibiotic resistance

    Scientific evidence and essential references

    • Parsons CL. Pathogenesis of interstitial cystitis (1996, 2003)
    • Kranjčec B et al. D-mannose vs antibiotic prophylaxis (World J Urol, 2014)
    • Jepson RG et al. Cranberry for UTIs (Cochrane Review)
    • Howell AB. PAC-A and bacterial anti-adhesion (J Urol, various studies)
    • McKay DL, Blumberg JB. Hibiscus and antioxidant activity (Nutr Rev)
    • EMA/ESCOP monographs on Birch

    Epithelial dysfunction and the loss of GAG layer integrity represent a central node in the pathogenesis of UTIs and IC. In this context, the integrated nutraceutical approach is a rational and modern strategy:

    • does not replace antibiotic therapy when necessary
    • but reduces the risk of recurrence
    • improves urothelial homeostasis
    • supports the physiology of the urinary tract

    Edited by Nico Martini